Phibro Animal Health (PAHC) EBITDA Margin (2012 - 2026)

Phibro Animal Health has reported EBITDA Margin for 15 years, with the latest figure at 12.14% in Q2 2026.

• On a quarterly basis, EBITDA Margin rose 323.0% year-over-year to 12.14% in Q2 2026; TTM through Jun 2026 was 12.81%, a 428.0% increase from a year earlier, with the FY2026 full-year figure at 12.81%, up 428.0% from the prior year.
• EBITDA Margin was 12.14% for Q2 2026 at Phibro Animal Health, up from 11.64% in the prior quarter.
• The five-year high for EBITDA Margin was 14.09% in Q3 2025, with the low at 0.31% in Q3 2023.
• Average EBITDA Margin over 5 years is 8.41%, with a median of 8.13% recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: EBITDA Margin plunged 620 bps in 2023, then soared 729 bps in 2025.
• Over 5 years, EBITDA Margin stood at 6.48% in 2022, then fell by 3 bps to 6.28% in 2023, then jumped by 31 bps to 8.26% in 2024, then jumped by 63 bps to 13.46% in 2025, then fell by 10 bps to 12.14% in 2026.
• The last three EBITDA Margin figures came in at 12.14% (Q2 2026), 11.64% (Q1 2026), and 13.46% (Q4 2025), per Business Quant data.